Oruka Therapeutics, Inc. · NASDAQ:ORKA

Agarwal Arjun sold 10,000 Oruka Therapeutics, Inc. shares (Form 4)

Traded Nov 12, 2026 · Filed Nov 13, 2026

On Nov 12, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 10,000 Oruka Therapeutics, Inc. shares at an average US$104.97 for US$1.05M under a trading plan, leaving 14,219 shares. Filed Nov 13, 2026 (Form 4).

Sold
10,000 shares
Price
US$104.97 average (US$101.98 to US$107.00)
Value
US$1.05M
Holding after
14,219 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Senior Vice President, Finance

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 12, 2026Common StockOption exercise8,542US$12.5022,761Direct
Nov 12, 2026Common StockOption exercise1,458US$34.3924,219Direct
Nov 12, 2026Common StockSale500US$101.9823,719Direct
Nov 12, 2026Common StockSale801US$103.1622,918Direct
Nov 12, 2026Common StockSale799US$104.2522,119Direct
Nov 12, 2026Common StockSale6,842US$105.2815,277Direct
Nov 12, 2026Common StockSale958US$106.1814,319Direct
Nov 12, 2026Common StockSale100US$107.0014,219Direct

Source

Download original · View original at SEC

Related